TRM Oncology appoints new Director of Scientific Content
TRM Oncology, a global strategic medical communications agency specializing in oncology, hematology and supportive cancer care has appointed Jubilee Stewart as the new Director of Scientific Content.
Based at The Hague office in the Netherlands, Jubilee Stewart will lead the European scientific content team interacting with business development colleagues and clients to assure high quality scientific content for the company’s medical communication and education projects.
Jubilee Stewart joins TRM Oncology from Novartis Oncology Global scientific communications department in the U.S.A where she worked as part of the global strategic team in launching Afinitor in RCC. She holds a PhD in biomedical sciences and has extensive experience as a medical writer in various medical communication agencies. In her former roles Jubilee Stewart was responsible for the scientific content of medical communication projects such as advisory boards and satellite symposia.
“We are pleased that Jubilee Stewart has joined TRM Oncology, ‘’ says Tatjana Romanyk, President of TRM Oncology. “The position demands stellar expertise in scientific communication and Jubilee brings a unique depth of experience having previously worked on industry and agency side.”
For further information call +31 70 30 67 200 or email to:
info@trmoncology.com
About TRM Oncology
TRM Oncology was founded in 2004 and has global headquarters in The Hague, Netherlands, Atlanta, U.S.A. and Moscow, Russia.
TRM Oncology offers a wide range of programs and services aimed to support different phases of the product lifecycle. These range from full-service offerings and strategic marketing consulting, to value proposition and operational plan development, and include the implementation of proposed actions including KOL management, medical education and communication, publication management congress and clinical trial support programs.
Our mission is to serve as a strategic partner to global pharmaceutical clients and professional associations by collaborating with them to identify and translate critical success factors into integrated, innovative and quality medical communication and market development programs that meet and exceed their objectives.